Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) - Acute placebo-controlled sleep laboratory studies with clonazepam

Author： Saletu M.   Anderer P.   Saletu-Zyhlarz G.   Prause W.   Semler B.   Zoghlami A.   Gruber G.   Hauer C.   Saletu B.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.11, Iss.2, 2001-04, pp. : 153-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olanzapine: Restless legs syndrome and periodic limb movements during sleep: 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1264, 2009-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite

The Restless Legs Syndrome Quality of Life Instrument (RLS-QLI) is a "reliable and valid" tool for assessing the impact of RLS on patients' lives

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 452, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

XP 13512, a prodrug of gabapentin, provides clinical benefit in restless legs syndrome (RLS)

By  

Inpharma, Vol. 1, Iss. 1471, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Dose Response of Gabapentin Enacarbil versus Placebo in Subjects with Moderate-to-Severe Primary Restless Legs Syndrome: An Integrated Analysis of Three 12-Week Studies

By VanMeter Susan A.  

CNS Drugs, Vol. 26, Iss. 9, 2012-09 ,pp. : 773-780

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for restless legs syndrome

By Ferini-Strambi Luigi   Marelli Sara  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 8, 2014-06 ,pp. : 1127-1138

Informa Healthcare

Access to resources Recommend Favorite